Advance in research for afatinib and its analogues, the multi-target tyrosine kinase inhibitor / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 2145-2149, 2014.
Artículo
en Chino
| WPRIM
| ID: wpr-860086
ABSTRACT
OBJECTIVE:
To review the lastest research progress afatinih and its analogues, which are multi-target tyrosine kinase inhibitor.METHODS:
By consulting references, the synthesis afatinib, the design, synthesis and antitumor activity its analogues are summarized, the antitumor activity, structure-activity relationship, pharmacokinetic research, adverse reaction are also summarized.RESULTS:
The research progress afatinib and its analogues was comprehensively summarized.CONCLUSION:
Although afatinib has much adverse reaction, it still has a good prospect and its analogues may be worth further studying.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Pharmaceutical Journal
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS